XILIO THERAPEUTICS INC (XLO) Stock Cash Flow
NASDAQ:XLO - Nasdaq - US98422T1007 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -54.30M | -58.24M | -76.40M | -88.22M | -75.80M | |||
| Depreciation Amortization | 1.70M | 1.64M | 1.90M | 1.85M | 1.50M | |||
| Change In Working Capital | 67.57M | 31.78M | -1.66M | 2.00M | -11.80M | |||
| Interest Paid | 0.00 | 62.00K | 573.00K | 560.00K | 490.00K | |||
| Other non cash items | 6.14M | 6.44M | 7.54M | 8.65M | 5.35M | |||
| OPERATING CASH FLOW | 21.10M | -18.38M | -68.62M | -75.72M | -80.75M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -58.00K | -36.00K | -486.00K | -1.87M | -1.10M | |||
| INVESTING CASH FLOW | -58.00K | -36.00K | -486.00K | -1.87M | -1.10M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -28.00K | -3.38M | -6.75M | -90.00K | -110.00K | |||
| Stock Issued/Repurchased | 33.10M | 32.58M | 202.00K | 20.00K | 261.53M | |||
| Other Financing Activity | N/A | N/A | N/A | 0.00 | -750.00K | |||
| FINANCING CASH FLOW | 33.07M | 29.20M | -6.55M | -70.00K | 260.67M | |||
| CHANGE IN CASH | 54.12M | 10.78M | -75.66M | -77.66M | 178.82M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 21.10M | -18.38M | -68.62M | -75.72M | -80.75M | |||
| Capital Expenditure | -58.00K | -36.00K | -486.00K | -1.87M | -1.10M | |||
| FREE CASH FLOW | 21.04M | -18.41M | -69.11M | -77.59M | -81.85M | |||
All data in USD